Expanding polysaccharide–protein coupling of glycoconjugate vaccines
Open Access
- 22 February 2022
- journal article
- editorial
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 298 (3) , 101755
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Vaccines 2020: The era of the digital vaccine is hereScience Translational Medicine, 2021
- Harnessing galactose oxidase in the development of a chemoenzymatic platform for glycoconjugate vaccine designJournal of Biological Chemistry, 2021
- Bacterial surface capsular polysaccharides from Streptococcus pneumoniae: A systematic review on structures, syntheses, and glycoconjugate vaccinesCarbohydrate Research, 2021
- Improving efficacy of glycoconjugate vaccines: from chemical conjugates to next generation constructsCurrent Opinion in Immunology, 2020
- The design of semi-synthetic and synthetic glycoconjugate vaccinesExpert Opinion on Drug Discovery, 2011
- Monitoring activation sites on polysaccharides by GC–MSAnalytical Biochemistry, 2006
- Vaccines consisting of periodate-cleaved oligosaccharides from the capsule of Haemophilus influenzae type b coupled to a protein carrier: structural and temporal requirements for priming in the human infant.The Journal of Immunology, 1986